Search

Search Constraints

You searched for: Author/Creator Cavender, Matthew A.

Search Results

23. Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2‐inhibitors versus other glucose‐lowering agents in real‐world clinical practice: Results from the CVD‐REAL study. Issue 8 (17th April 2018)

24. Relationship of Race/Ethnicity With Door‐to‐Balloon Time and Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST‐Elevation Myocardial Infarction: Findings From Get With the Guidelines–Coronary Artery Disease. Issue 12 (24th September 2013)

26. Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)". Issue 9 (27th February 2018)

27. Response to Letter Regarding Article, "Heart Failure, Saxagliptin and Diabetes Mellitus. Issue 6 (11th August 2015)

28. Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care). Issue 20 (16th May 2017)

29. Total cardiovascular events analysis of the EXAMINE trial in patients with type 2 diabetes and recent acute coronary syndrome. Issue 8 (16th August 2018)

30. Vorapaxar in Patients With Diabetes Mellitus and Previous Myocardial Infarction. Issue 12 (24th March 2015)